Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Insight Services | PRODUCT CODE: 1987215

Cover Image

PUBLISHER: Global Insight Services | PRODUCT CODE: 1987215

Radiation Dose Management Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Deployment, End User, Functionality, Solutions

PUBLISHED:
PAGES: 350 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4750
PDF & Excel (Site License)
USD 5750
PDF & Excel (Enterprise License)
USD 6750

Add to Cart

The global Radiation Dose Management Market is projected to grow from $3.9 billion in 2025 to $7.0 billion by 2035, at a compound annual growth rate (CAGR) of 5.9%. Growth is driven by increasing regulatory requirements for radiation safety, advancements in healthcare IT solutions, and rising awareness of radiation exposure risks among healthcare providers. The Radiation Dose Management Market is characterized by key segments such as software solutions, which hold approximately 55% of the market share, and services, accounting for around 45%. Major product categories include dose tracking, monitoring, and analytics software, as well as consulting and support services. The market is moderately consolidated, with a few leading players dominating the landscape. Volume insights indicate a growing number of installations, particularly in hospitals and diagnostic imaging centers, driven by increasing regulatory requirements and the need for patient safety.

The competitive landscape features a mix of global and regional players, with global companies like GE Healthcare, Siemens Healthineers, and Philips Healthcare leading the market. The degree of innovation is high, with continuous advancements in software capabilities and integration with hospital information systems. Mergers and acquisitions, as well as strategic partnerships, are common as companies aim to expand their technological capabilities and geographic reach. Recent trends indicate a focus on developing AI-driven solutions to enhance dose optimization and compliance.

Market Segmentation
TypeSoftware, Services, Others
ProductRadiation Dose Tracking Software, Radiation Dose Analysis Software, Radiation Dose Reporting Software, Others
ServicesConsulting Services, Implementation Services, Support and Maintenance Services, Others
TechnologyCloud-based, On-premise, Hybrid, Others
ApplicationComputed Tomography, Fluoroscopy and Interventional Imaging, Radiography and Mammography, Nuclear Medicine, Others
DeploymentStandalone, Integrated, Others
End UserHospitals, Diagnostic Centers, Ambulatory Care Settings, Research Institutes, Others
FunctionalityDose Monitoring, Dose Optimization, Dose Reporting, Others
SolutionsPatient Dose Management, Staff Dose Management, Others

In the Radiation Dose Management Market, the 'Type' segment is pivotal as it categorizes solutions into software and services, with software solutions dominating due to their ability to integrate seamlessly with existing healthcare IT systems. These solutions are crucial for tracking and optimizing radiation exposure, driven by the increasing adoption of electronic health records (EHRs) and regulatory compliance needs. The services subsegment, including consulting and training, is also gaining traction as healthcare providers seek to enhance operational efficiency and patient safety.

The 'Technology' segment focuses on the methodologies employed in dose management, with automated solutions leading the market. Automation is essential for reducing manual errors and improving data accuracy, which is critical in high-stakes environments like hospitals and diagnostic centers. The demand for advanced technologies such as AI and machine learning is growing, as they offer predictive analytics capabilities that enhance decision-making and patient outcomes. This trend is particularly pronounced in developed regions with mature healthcare infrastructures.

Within the 'Application' segment, diagnostic and interventional radiology applications are at the forefront. These applications are vital for minimizing radiation exposure during imaging procedures, a concern that is increasingly prioritized by healthcare providers. The rising prevalence of chronic diseases necessitating frequent imaging, such as cancer and cardiovascular conditions, is a significant driver. Additionally, the push for personalized medicine and precision diagnostics is further propelling the adoption of dose management solutions in these applications.

The 'End User' segment is characterized by its focus on healthcare facilities, with hospitals and diagnostic imaging centers being the primary users. These institutions are under pressure to comply with stringent regulatory standards and improve patient safety, driving the adoption of radiation dose management solutions. The trend towards value-based care and the increasing need to manage operational costs are also contributing to the growth of this segment. Smaller clinics and outpatient facilities are emerging as notable users as they expand their imaging capabilities.

In the 'Component' segment, the market is divided into software and hardware components, with software components dominating due to their flexibility and ease of integration. Software solutions are crucial for real-time monitoring and reporting of radiation doses, which are essential for compliance and quality assurance. The hardware segment, although smaller, is seeing growth driven by advancements in imaging equipment that require sophisticated dose management capabilities. This segment is expected to benefit from ongoing technological innovations and the increasing digitization of healthcare services.

Geographical Overview

North America: The Radiation Dose Management Market in North America is highly mature, driven by stringent regulatory frameworks and advanced healthcare infrastructure. The United States and Canada are key players, with significant investments in medical imaging technologies and radiation safety protocols. The demand is primarily driven by the healthcare and medical research industries, focusing on patient safety and compliance with regulatory standards.

Europe: Europe exhibits moderate market maturity, with a strong emphasis on regulatory compliance and patient safety in radiation dose management. Germany, France, and the United Kingdom are notable countries contributing to market growth. The region's demand is driven by the healthcare sector, particularly in diagnostic imaging and radiotherapy, supported by robust government regulations and initiatives.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the Radiation Dose Management Market, driven by expanding healthcare infrastructure and increasing awareness of radiation safety. Key countries include China, Japan, and India, where rising healthcare investments and technological advancements in medical imaging are prominent. The market is in a developmental stage, with significant potential for growth.

Latin America: The market in Latin America is in the nascent stage, with growing awareness and adoption of radiation dose management solutions. Brazil and Mexico are notable countries driving demand, primarily through the healthcare sector's focus on improving patient safety and compliance with international standards. The region is gradually adopting advanced medical imaging technologies.

Middle East & Africa: The Radiation Dose Management Market in the Middle East & Africa is emerging, with uneven market maturity across the region. The United Arab Emirates and South Africa are key countries, where investments in healthcare infrastructure and medical imaging technologies are increasing. The market is driven by the need for enhanced patient safety and adherence to international radiation safety standards.

Key Trends and Drivers

Trend 1: Increasing Regulatory Compliance

The Radiation Dose Management Market is significantly influenced by stringent regulatory requirements aimed at patient safety and dose optimization. Regulatory bodies such as the FDA and the European Commission have established guidelines that mandate healthcare providers to monitor and manage radiation doses effectively. This has led to increased adoption of dose management solutions as healthcare facilities strive to comply with these regulations, ensuring patient safety and minimizing unnecessary exposure to radiation.

Trend 2: Technological Advancements in Dose Management Solutions

Technological innovation is a key driver in the Radiation Dose Management Market, with advancements in software solutions that offer enhanced capabilities for tracking, analyzing, and reporting radiation doses. These solutions leverage artificial intelligence and machine learning to provide predictive analytics, enabling healthcare providers to optimize radiation use and improve patient outcomes. The integration of these advanced technologies is facilitating more precise and efficient dose management practices.

Trend 3: Growing Adoption of Electronic Health Records (EHR)

The integration of radiation dose management systems with Electronic Health Records (EHR) is becoming increasingly prevalent. This trend is driven by the need for seamless data exchange and comprehensive patient records that include radiation exposure history. EHR integration allows for better tracking and management of patient doses, improving clinical decision-making and enhancing the overall quality of care. This interoperability is crucial for achieving holistic patient management and compliance with regulatory standards.

Trend 4: Rising Awareness of Radiation Safety

There is a growing awareness among healthcare providers and patients about the importance of radiation safety, which is propelling the demand for dose management solutions. Educational initiatives and campaigns by healthcare organizations and regulatory bodies are highlighting the risks associated with excessive radiation exposure and the benefits of dose optimization. This heightened awareness is encouraging healthcare facilities to invest in dose management technologies to ensure safer imaging practices.

Trend 5: Expansion of Diagnostic Imaging Procedures

The increasing volume of diagnostic imaging procedures, such as CT scans and X-rays, is a significant growth driver for the Radiation Dose Management Market. As the demand for diagnostic imaging rises, so does the need for effective dose management to prevent overexposure to radiation. This trend is particularly evident in developed regions where advanced imaging technologies are widely used, prompting healthcare providers to adopt comprehensive dose management solutions to maintain patient safety and adhere to regulatory standards.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS26729

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software
    • 4.1.2 Services
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Radiation Dose Tracking Software
    • 4.2.2 Radiation Dose Analysis Software
    • 4.2.3 Radiation Dose Reporting Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Implementation Services
    • 4.3.3 Support and Maintenance Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cloud-based
    • 4.4.2 On-premise
    • 4.4.3 Hybrid
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Computed Tomography
    • 4.5.2 Fluoroscopy and Interventional Imaging
    • 4.5.3 Radiography and Mammography
    • 4.5.4 Nuclear Medicine
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Centers
    • 4.6.3 Ambulatory Care Settings
    • 4.6.4 Research Institutes
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Dose Monitoring
    • 4.7.2 Dose Optimization
    • 4.7.3 Dose Reporting
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 Standalone
    • 4.8.2 Integrated
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Patient Dose Management
    • 4.9.2 Staff Dose Management
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Deployment
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Deployment
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Deployment
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Deployment
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Deployment
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Deployment
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Deployment
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Deployment
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Deployment
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Deployment
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Deployment
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Deployment
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Deployment
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Deployment
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Deployment
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Deployment
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Deployment
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Deployment
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Deployment
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Deployment
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Deployment
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Deployment
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Deployment
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Deployment
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 GE Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Siemens Healthineers
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Canon Medical Systems
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Fujifilm Holdings Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bayer AG
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Bracco Imaging
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Sectra AB
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Agfa HealthCare
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Guerbet
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Qaelum NV
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Medsquare
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 PACSHealth LLC
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Novarad Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Radiation Detection Company
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Landauer Inc
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Mirion Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Unfors RaySafe
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Lifelines Neuro Company
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Varian Medical Systems
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!